Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 581

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 581
---
 the Units being offered, the “Public Shares”), generating gross proceeds of $ 60,000,000, which is described in Note 3. On February 17, 2023, the underwriters exercised their over -allotmentoption in full. The closing of the issuance and sale of the additional Units occurred (the “Over -AllotmentOption Units”) on February 21, 2023. The total aggregate issuance by the Company of 900,000Over -AllotmentOption Units at a price of $ 10.00per unit generated total gross proceeds of $ 9,000,000. Simultaneously with the consummation of the Initial Public Offering and the sale of the Units, the Company consummated the private placement (the “Private Placement”) of 430,000Units (the “Private Placement Units”), to Bellevue Global Life Sciences Investors LLC (the “Sponsor”) at a price of $ 10.00per Placement Unit, for an aggregate purchase price of $ 4,300,000. Each Unit and Private Placement Unit consists of oneshare of common stock, par value $ 0.0001(the “Common Stock”), a warrant to purchase oneshare of Common Stock (the “Public Warrants” and “Private Placement Warrants” and collectively, the “Warrants”) and oneright which entitles the holder thereof to receive one -tenth(1/10) of a share of common stock (the “Public Rights” and Private Placement Rights” and collectively, the “Rights”), as described in Notes 3 and 4. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting fees and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post -transactioncompany owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target